Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
dc.contributor.authorDUMOULIN, C.
dc.contributor.authorONG, N.
dc.contributor.authorRAMAROSON, H.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorLETINIER, Louis
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMIREMONT-SALAME, Marie Ghada
ORCID: 0000-0002-6468-8903
IDREF: 153165766
dc.contributor.authorGILLERON, Veronique
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDAVELUY, Amelie
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPERINO, Justine
ORCID: 0000-0003-0039-0734
IDREF: 254309690
dc.date.accessioned2022-07-15T14:28:10Z
dc.date.available2022-07-15T14:28:10Z
dc.date.issued2022-06
dc.date.conference2022-06-14
dc.identifier.issn0767-3981en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/140510
dc.descriptionMeeting abstracten_US
dc.description.abstractEnIntroduction: As soon as the lockdown began, during the COVID-19 pandemic, first cases of overdoses were reported with opioids and cocaine to the French Addictovigilance Network [1]. However, little information was available on substance use-related hospitalizations (H-SPA). The objective of this study was to describe changes in the relative incidence of H-SPA before, during, and after the lockdown, and to describe the characteristics of hospitalizations and patients. Material and methods: This retrospective study was conducted on patients hospitalized at a University Hospital from January to July 2020 in the context of use of methadone, buprenorphine, benzodiazepines, heroin, morphine, codeine, cocaine, ecstasy, and alcohol, using the database of the Programme de medicalisation des systèmes d'information. Three time periods were defined for the analysis: before (01/01–16/03), during (17/03–10/05), and after the lockdown (11/05–31/07). These results were compared to the average of the data analyzed between 2017 and 2019 at the same three time periods. Results: In this study, 5,674 patients and 6,135 stays were included. H-SPA had decreased by 24% during the year of the pandemic, in particular during lockdown with a 57.6% decrease compared to previous years. In contrast, methadone was associated with a 233.3% increase in post-lockdown hospitalizations compared to 2017. Among patients hospitalized after methadone use, 4 had no known history of opiate use, 6 were known opiate/methadone users without methadone treatment, 7 were being treated with methadone. In 2020, H-SPA were more severe and involved drug-using patients with cardiovascular disease. Methadone/cocaine association was reported in 1/4 of deaths during the lockdown. Discussion/Conclusion: During the year of the pandemic and especially during the lockdown, H-SPA decreased but were more severe. Severe H-SPA were more likely to occur in drug-using patients with cardiovascular disease. This study highlights also a strong increase of hospitalizations related to methadone consumption (in opioid-naive subjects, or not) since the lockdown.
dc.language.isoENen_US
dc.subject.enAddictovigilance
dc.subject.enMethadone
dc.subject.enCocaine
dc.subject.enLockdown
dc.subject.enCOVID-19
dc.subject.enHospitalization
dc.title.enHospitalizations after substance use in a University Hospital during the COVID-19 pandemic
dc.typeArticle de revueen_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.journalFundamental and Clinical Pharmacologyen_US
bordeaux.page96-97en_US
bordeaux.volume36en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.conference.titleAnnual Meeting of French Society of Pharmacology and Therapeutics
bordeaux.countryfr
bordeaux.teamAHEAD_BPHen_US
bordeaux.teamPHARES_BPHen_US
bordeaux.conference.cityLille
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03724868
hal.version1
hal.date.transferred2022-07-15T14:33:33Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Fundamental%20and%20Clinical%20Pharmacology&rft.date=2022-06&rft.volume=36&rft.spage=96-97&rft.epage=96-97&rft.eissn=0767-3981&rft.issn=0767-3981&rft.au=DUMOULIN,%20C.&ONG,%20N.&RAMAROSON,%20H.&LETINIER,%20Louis&MIREMONT-SALAME,%20Marie%20Ghada&rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem